GoAI
Get started
WORK Medical Technology Group Ltd. Class A logo

WORK Medical Technology Group Ltd. Class A

WOK

NASDAQHealthcareMedical - Specialties

Open in GoAI

Previous close

$2.28

−$0.02 · -0.87%

Aug 21, 4:00 PM ET

WOK company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

49

Fair Value

Momentum

32

Weakening

Sentiment

47

Mixed

Risk resilience

25

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

WORK Medical Technology Group LTD, through with its subsidiaries, manufactures and sells medical consumables and devices in the People's Republic of China and internationally. The company offers medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, yankauer suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half masks; visualized prostatic dilatation catheters; and nebulizer kits, SPO2 sensors, nasogastric tubes, personal protective equipment, hygiene and skincare products, cleaners for household use, and non-powered air-purifying particle respirators. It also engages in the research and development of biological and medical technology; and sale of chemical products. The company serves hospitals, pharmacies, and medical institutions. It exports its products to approximately 30 countries in Asia, Africa, Europe, North America, South America, and Oceania. WORK Medical Technology Group LTD was founded in 2002 and is based in Hangzhou City, China.

Industry
Medical - Specialties
Sector
Healthcare
Headquarters
CN
CEO
Shuang Wu
Listed since
Aug 23, 2024
Employees
238

Market position

Day range

Current $2.28

52-week range

Current $2.28

Open
$2.30
Previous close
$2.30
Volume
247.42K
0.27× average
Average volume
911.49K
Average daily volume
Market cap
5.51M USD
Beta
1.61
Market reference 1
50-day average
$2.6166
-12.86% below average
200-day average
$5,836.13
-99.96% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
21.71B USD
P/E (TTM)
-0.01×
P/B (TTM)
0×
P/S (TTM)
0.51×
EV / EBITDA
63,966.33×
Earnings yield
-0.00%
Free cash flow yield
0.02%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
12.25%
Operating margin
-41.68%
Net margin
-41.95%
Return on equity
-5.85%
Return on assets
-3.23%
Return on invested capital
-9.04%

Financial health

Debt / equity
0.22×
Current ratio
1.71×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends37%12%-13%-38%Gross margin, FY2021: 18.84%Gross margin, FY2022: 22.42%Gross margin, FY2023: 30.54%Gross margin, FY2024: 24.93%Gross margin, FY2025: 23.81%Operating margin, FY2021: 16.73%Operating margin, FY2022: 9.26%Operating margin, FY2023: 3.59%Operating margin, FY2024: -32.14%Operating margin, FY2025: -25.34%Net margin, FY2021: 12.99%Net margin, FY2022: 4.39%Net margin, FY2023: 0.83%Net margin, FY2024: -30.35%Net margin, FY2025: -10.89%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 18.84%. Gross margin FY2022 22.42%. Gross margin FY2023 30.54%. Gross margin FY2024 24.93%. Gross margin FY2025 23.81%. Operating margin FY2021 16.73%. Operating margin FY2022 9.26%. Operating margin FY2023 3.59%. Operating margin FY2024 -32.14%. Operating margin FY2025 -25.34%. Net margin FY2021 12.99%. Net margin FY2022 4.39%. Net margin FY2023 0.83%. Net margin FY2024 -30.35%. Net margin FY2025 -10.89%.

Income trends

Revenue

9.85M USD-14.41%

Operating income

−2.5M USD+32.51%

Net income

−1.07M USD+69.28%
Income trends across reported periods50.82M USD30.99M USD11.17M USD−8.65M USDRevenue, FY2021: 45.86M USDRevenue, FY2022: 19.71M USDRevenue, FY2023: 13.57M USDRevenue, FY2024: 11.51M USDRevenue, FY2025: 9.85M USDOperating income, FY2021: 7.67M USDOperating income, FY2022: 1.82M USDOperating income, FY2023: 486.46K USDOperating income, FY2024: −3.7M USDOperating income, FY2025: −2.5M USDNet income, FY2021: 5.96M USDNet income, FY2022: 865.21K USDNet income, FY2023: 112.03K USDNet income, FY2024: −3.49M USDNet income, FY2025: −1.07M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 45.86M USD. Revenue FY2022 19.71M USD. Revenue FY2023 13.57M USD. Revenue FY2024 11.51M USD. Revenue FY2025 9.85M USD. Operating income FY2021 7.67M USD. Operating income FY2022 1.82M USD. Operating income FY2023 486.46K USD. Operating income FY2024 −3.7M USD. Operating income FY2025 −2.5M USD. Net income FY2021 5.96M USD. Net income FY2022 865.21K USD. Net income FY2023 112.03K USD. Net income FY2024 −3.49M USD. Net income FY2025 −1.07M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue9.85M USD11.51M USD13.57M USD19.71M USD45.86M USD
Cost of goods sold7.5M USD8.64M USD9.42M USD15.29M USD37.22M USD
Gross profit2.34M USD2.87M USD4.14M USD4.42M USD8.64M USD
Research and development435.31K USD302.51K USD301.64K USD183.9K USD186.45K USD
Selling, general, and administrative4.41M USD6.61M USD3.43M USD3.6M USD4.49M USD
Operating expenses4.84M USD6.57M USD3.66M USD2.59M USD965.34K USD
Interest income181.68K USD11.73K USD———
Interest expense503.52K USD557.57K USD367.32K USD351K USD329.52K USD
Depreciation and amortization917.82K USD1.39M USD1.6M USD3.26M USD4.19M USD
Operating income−2.5M USD−3.7M USD486.46K USD1.82M USD7.67M USD
Net income−1.07M USD−3.49M USD112.03K USD865.21K USD5.96M USD

Company facts updated Aug 24, 2026.

WOK news

globenewswire.com

WORK Medical Announces 1-for-100 Reverse Stock Split Effective June 18, 2026

Auckland, New Zealand, June 16, 2026 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, today announced that it will effect a…

Read source
globenewswire.com

WORK Medical Technology Group Participated in 2026 CBA-China Annual Conference

Deepening Engagement with the Global Biopharmaceutical Community Auckland, New Zealand, June 05, 2026 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical", the "Company" or "we"), a…

Read source
globenewswire.com

WORK Medical Technology Group Participated in 2026 CBA-China Annual Conference

Deepening Engagement with the Global Biopharmaceutical Community Auckland, New Zealand, June 05, 2026 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical”, the “Company” or “we”), a…

Read source
globenewswire.com

WORK Medical Technology Group Establishes U.S. Subsidiary to Advance Global Expansion and Reinforce Long-Term Growth Strategy

Hangzhou, China, June 03, 2026 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical”, the “Company” or “we”), a supplier of medical devices in China today announced the establishment of its…

Read source

Corporate actions

Corporate action history

Stock split

Effective Jun 18, 2026

1:100

Stock split

Effective Dec 29, 2025

1:100

Stock split

Effective Oct 21, 2025

1:100

WOK peers

Amgen Inc. logo

AMGN

Amgen Inc.

$439.33

+1.29%

Gilead Sciences, Inc. logo

GILD

Gilead Sciences, Inc.

$146.12

+1.87%

Vertex Pharmaceuticals Incorporated logo

VRTX

Vertex Pharmaceuticals Incorporated

$548.05

+1.44%

Intuitive Surgical, Inc. logo

ISRG

Intuitive Surgical, Inc.

$378.81

+1.16%

Sanofi logo

SNY

Sanofi

$45.85

+1.55%

Regeneron Pharmaceuticals, Inc. logo

REGN

Regeneron Pharmaceuticals, Inc.

$834.04

+0.90%

Continue in GoAI

Research WOK

research.disclaimer